Outcomes of antenatally diagnosed fetal cardiac tumors: a 10-year experience at a single tertiary referral center

Basit Öğe Kaydı
dc.contributor.authorOkmen, Firat
dc.contributor.authorEkici, Huseyin
dc.contributor.authorHortu, Ismet
dc.contributor.authorImamoglu, Metehan
dc.contributor.authorUcar, Burcu
dc.contributor.authorErgenoglu, Ahmet Mete
dc.contributor.authorSagol, Sermet
dc.date.accessioned2020-12-01T11:58:03Z
dc.date.available2020-12-01T11:58:03Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective the purpose of this study was to analyze the clinical and perinatal outcomes along with ultrasonographic characteristics of fetuses with a cardiac tumor. Methods the data were obtained retrospectively between January 2010 and December 2019 in a tertiary referral center. the Cardiovascular Profile Score (CVPS) was used for the diagnosis of heart failure. Clinical outcomes of the cases identified in the postnatal period were analyzed. Results Fourteen cases were evaluated with the fetal cardiac tumor. One case made the decision to terminate the pregnancy. Perinatal death was seen in 4 (30.7 %) cases out of 13 cases. in 3/14 (21.4%) cases, a solitary cardiac tumor was found while multiple cardiac tumors were found in 11/14 (78.6%) cases. All living cases 9/9 (100%) had the diagnosis of tuberous sclerosis complex (TSC). When the cases which survived were compared with the cases which died during the prenatal period, a significant difference in tumors' biggest diameters (16.44 +/- 5.12 mm vs. 32.25 +/- 9.28 mm;p: .011, respectively) was found. No statistically significant difference was found in the number of the tumor(s) and heart failure. Conclusion Fetal cardiac tumors can have serious perinatal mortality. the cardiac tumor size was found to be associated with perinatal mortality. the survival is not different between the cases with solitary and multiple tumors and those with and without congestive heart failure.en_US
dc.identifier.doi10.1080/14767058.2020.1822316en_US
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.pmid32954877en_US
dc.identifier.scopus2-s2.0-85091178280en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1080/14767058.2020.1822316
dc.identifier.urihttps://hdl.handle.net/11454/61911
dc.identifier.wosWOS:000571274800001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFetal cardiac tumoren_US
dc.subjectfetal rhabdomyomaen_US
dc.subjecttuberous sclerosisen_US
dc.subjectprenatal diagnosisen_US
dc.titleOutcomes of antenatally diagnosed fetal cardiac tumors: a 10-year experience at a single tertiary referral centeren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu